Schedule 13G ownership disclosure

ADIAL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00688A106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-004583
Form type
SC 13G/A
Filer
ADIAL PHARMACEUTICALS, INC.
CIK
CIK 1513525
Filed
Feb 14, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub